CytomX Therapeutics CTMX Net Income
Net Income at other companies
Other financials
Where this comes from
Reported directly by CytomX Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic.
The official record: CytomX Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about CytomX Therapeutics's net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is CytomX Therapeutics's net income?
- CytomX Therapeutics (CTMX) reported net income of -$18.25M in Q1 2026.
- How has CytomX Therapeutics's net income changed year-over-year?
- CytomX Therapeutics's net income decreased by 177.6% year-over-year, from $23.53M to -$18.25M.
- What is the long-term trend for CytomX Therapeutics's net income?
- Over 3 years (2021 to 2025), CytomX Therapeutics's net income has grown at a -46.9% compound annual growth rate (CAGR), from -$115.87M to -$17.37M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.